| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing “amino acid–like” molecule (not incorporated into proteins). It’s abundant in many tissues and is best thought of as a homeostatic modulator rather than a direct cytotoxin.Core biology themes: -Osmoregulation / membrane stabilization -Mitochondrial support + anti-oxidant tone (indirect) -Calcium handling modulation -Anti-inflammatory signaling (context-dependent) -Bile acid conjugation (tauroursodeoxycholic-type physiology, but taurine itself is a conjugating substrate) Cancer relevance (preclinical/adjunct framing): -Often discussed as protective (normal-tissue protection) and stress-modulating, not a primary anti-cancer agent. -May influence redox balance, ER stress, and inflammation, which can indirectly affect tumor biology or therapy tolerance (model-dependent). -ROS axis: tends to reduce oxidative injury (indirect) -NRF2: sometimes reported as part of antioxidant adaptation, but not a “core direct target”Amino acid that benefits the heart, brain and immune system. Taurine, an organic compound containing sulfur in its chemical structure, possesses anti-inflammatory, anti-oxidant, and various physiological functions within the cardiovascular, kidney, endocrine, and immune systems. Also an LDH inhibitor -Neuroprotection: helps protect neurons against excitotoxicity (e.g., glutamate damage) and ROS stress. -Anti-oxidative action: scavenges ROS, reducing oxidative stress seen in AD brains. -Anti-inflammatory -Calcium homeostasis Helps maintain intracellular calcium balance, disrupted in AD. -Amyloid-beta toxicity May reduce Aβ-induced neurotoxicity and cell death in vitro. -Tau pathology: possible reduction of tau hyperphosphorylation. -Memory and cognition may improve learning and memory.
Time-Scale Flag (TSF): P / R / G
Alzheimer’s Disease (AD)-Oriented Time-Scale Flagged Pathway Table
Time-Scale Flag (TSF): P / R / G
|
| Source: |
| Type: |
| Tumor Microenvironment: Cancer cells often thrive in a more acidic environment compared to normal cells. This is partly due to the metabolic processes of cancer cells, which can produce lactic acid and other acidic byproducts. The acidic microenvironment can promote tumor growth and invasion. Many tumors exhibit an acidic microenvironment. This is largely due to the high rate of glycolysis (often referred to as the Warburg effect), even in the presence of oxygen, leading to lactate production. Acidification is thought to promote invasion, metastasis, and resistance to certain chemotherapies. The body maintains a relatively stable pH in the blood (around 7.4). However, the pH of tissues can vary, and tumors can exhibit a lower pH. -Normal tissues have a higher extracellular pH than intracellular pH, in cancer is exactly the opposite. (inversion of the pH gradient). Cancer cells often overexpress proton pumps (such as V-ATPase) and transporters that actively extrude protons (H⁺) to maintain an intracellular pH conducive to their growth. Inhibiting these pumps can lead to intracellular acidification and potentially induce apoptosis or render cancer cells more vulnerable to other treatments. Normal pH levels in the body: Nasal: ~6.3 pH Mouth/saliva: 6.2-7.6 pH Stomach: 1-3 pH Small Intestine: 5.9-6.8 pH Colon/Large Intestine: 6.8-7 pH |
| 3950- | Taur, | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes |
| - | Review, | Diabetic, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:158 Target#:250 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid